Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
El hidrobromuro de valticetina se considera un nuevo fármaco antidepresivo multimodelo. Los estudios in vitro han demostrado que puede antagonizar los receptores 5-HT3, 5-HT7 y 5-HT1D, activar los receptores 5-HT1A y activar parcialmente los receptores 5- HT1B e inhibir el transporte de 5-HT.
Para el tratamiento de la depresión leve a moderada o grave Depresión neurogénica y reactiva Fisioterapia, especialmente distrés gastrointestinal Depresión Ansiedad Depresión en pacientes con dependencia del alcohol durante la abstinencia.
PRODUCTOS POR GRUPO : API e intermedios
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.